Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Therapeutic response of cyclosporine and outcome in steroid resistant nephrotic syndrome

스테로이드 저항성 신증후군에서 cyclosporine 치료 반응 및 결과

  • Choi, Hyung Soon (Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Lee, Joo Hoon (Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Park, Young Seo (Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine)
  • 최형순 (울산대학교 의과대학 서울아산병원 소아과학교실) ;
  • 이주훈 (울산대학교 의과대학 서울아산병원 소아과학교실) ;
  • 박영서 (울산대학교 의과대학 서울아산병원 소아과학교실)
  • Received : 2007.09.18
  • Accepted : 2007.10.22
  • Published : 2008.03.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose : The aim of our study was to evaluate the therapeutic response to cyclosporine, time to remission and side effects in steroid resistant nephrotic syndrome (SRNS). Methods : This study included 22 children with idiopathic SRNS who were treated with cyclosporine between June 1989 and August 2006. Medical records were reviewed retrospectively. Results : The mean age of patients at diagnosis was $5.2{\pm}3.3\;years$. The male to female ratio was 1.2:1. Pre-treatment renal biopsies showed minimal change (MCD) in 12 (54.5%), focal segmental glomerulosclerosis (FSGS) in 8 (36.4%), membranous nephropathy (MGN) in one (4.5%) and mesangioproliferative glomerulonephritis in one (4.5%). 15 (68.2%) patients responded to cyclosporine, of whom 11 (91.6%) patients were MCD, 3 (37.5%) patients FSGS, and 1 patient MGN (MCD vs FSGS, P<0.05). The time to remission in patients who responded to cyclosporine was $31.5{\pm}15.2\;days$. Four of the 15 cyclosporine responders maintained complete remission even after cessation of the medication Seven still received cyclosporine, 2 were intermittently treated with steroids after discontinuation of cyclosporine, and two were treated with cyclosporine and steroids. The mean duration of cyclosporine therapy was $546.5{\pm}346.2$, $1,392.9{\pm}439.7$, $439.5{\pm}84.1$, and $433.5{\pm}74.2$ days, respectively. We performed post-treatment biopsies in 8 patients and partial interstitial fibrosis and tubular atrophy were found in two. Conclusion : The thrapeutic response of cyclosporine is good in steroid resistant nephrotic syndrome, especially in minimal change. But, there is a problem of long term cyclosporine dependency.

목 적 : 스테로이드 저항성 신증후군에서 cyclosporine의 반응 효과, 반응 시기, 부작용 및 다른 치료제에 대한 반응을 비교 분석하고자 하였다. 방 법 : 1989년 6월부터 2006년 8월까지 서울아산병원 소아과를 방문한 신증후군 환아 중 초기에 스테로이드 치료에 반응하지 않아 신장 조직 검사 시행 후 cyclosporine을 사용한 22명을 대상으로 cyclosporine의 반응 효과, 반응 시기, 부작용 및 다른 치료제에 대한 반응을 후향적으로 조사하였다. 결 과 : 총 22명중 미세변화형은 12명(54.5%), 국소 분절 사구체 경화증 8명(36.4%), 메산지움 증식 사구체 신염 1명(4.5%), 막성 사구체 신염 1명(4.5%) 이었다. 진단 당시의 평균 연령은 $5.2{\pm}3.3$세이었으며 남녀 비는 1.2:1 이었다. 22명중 15명(68.2%)에서 cyclosporine에 반응하였는데, 이중 미세변화형이었던 환아는 11명(91.7%), 국소 분절 사구체경화증이었던 환아는 3명(37.5%)(미세변화형 vs 국소 분절 사구체경화증, P<0.05), 그리고 막성 사구체 신염 1명이었다. 관해 시기는 cyclosporine 사용 후 $31.5{\pm}15.2$일이었다. Cyclosporine에 반응을 보인 15명 중 4명은 약물 사용 없이 관해 상태이고, 7명은 cyclosporine 사용 중이며, 2명은 cyclosporine 중단 후 스테로이드를 간헐적으로 사용하고 있고, 2명은 cyclosporine과 스테로이드를 함께 투여하고 있다. 이들의 cyclosporine 사용 기간은 각각 $546.5{\pm}346.2$일, $1,392.9{\pm}439.7$일, $439.5{\pm}84.1$일, $433.5{\pm}74.2$일이었다. Cyclosporine 사용 기간 중 혈청 크레아티닌의 변화는 없었으나 신장조직검사를 시행한 8 명중 2 명에서 간질의 섬유화와 세뇨관의 위축이 부분적으로 관찰되었다. 결 론 : 스테로이드 저항성 신증후군에 있어 cyclosporine의 반응은 비교적 좋은 편이고, 특히 미세변화 신증후군에서 그 효과가 높다. 그러나 관해를 유지하기 위해서는 장기간 사용하여야 하는 문제점이 있다.

Keywords

References

  1. Tarshish P, Tobin IN, Bernstein J, Edelmann CM Jr. Prognostic significance of the early course of minimal change nephrotic syndrome: Report of the International Study of Kidney Disease in Children. J Am Soc Nephrol 1997;8:769-76
  2. Frassinetti Castelo Branco Camurca Fernandes P, Bezerra Da Silvia G Jr, De Sousa Barros FA, Costa Oliveira CM, Kubrusly M, Evangelista JB Jr. Treatment of steroid-resistant nephrotic syndrome with cyclosporine: study of 17 cases and a literature review. J Nephrol 2005;18:711-20
  3. Nammalwar BR, Vijaykumar M, Prahlad N, Jain DV. Steroid resistant nephrotic syndrome is sustained remission attainable. Indian Pediatr 2006;43:39-43
  4. McBryde KD, Kershaw DB, Smoyer WE. Pediatric steroid-resistant nephrotic syndrome. Curr Probl Pediatr Adolesc Health Care 2001;31:280-307 https://doi.org/10.1067/mps.2001.119800
  5. Hamed RM. Treatment of idiopathic nephrotic syndrome with cyclosporin A in children. J Nephrol 1997;10:266-70
  6. Meyrier A. Treatment of idiopathic nephrotic syndrome with cyclosporine A. J Nephrol 1997;10:14-24
  7. Hoyer PF, Brodeh J. Initial treatment of idiopathic nephritic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial. J Am Soc Nephrol 2006;17:1151-7 https://doi.org/10.1681/ASN.2005090922
  8. Sohn EK, Cho BS. A clinical trial of cyclosporine A in childhood nephrotic syndrome. Korean J Nephrol 1989;8:306-14
  9. Hong IH, Ko CW, Koo JH, Cho BS, Kim JH, Y ook JW, Kim PK. Long-term Cyclosporine A(Cypol(R)) therapy in children with idiopathic nephrotic syndrome. Korean J Nephrol 2001;20:242-9
  10. Mendoza SA, Reznik VM, Griswold WR, Krensky AM, Yorgin PD, Tune BM. Treatment of steroid-resistant focal segmental glomerulosclerosis with pulse methylprednisolone and alkylating agents. Pediatr Nephrol 1990;4:303-7 https://doi.org/10.1007/BF00862503
  11. Tune BM, Kirpekar R, Sibley RK, Reznik VM, Griswold WR, Mendoza SA. Intravenous methylprednisolone and oral alkylating agent therapy of prednisone-resistant pediatric focal segmental glomerulosclerosis: a long-term follow-up. Clin Nephrol 1995;43:84-8
  12. Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children. Kidney Int 1978;13:159-65 https://doi.org/10.1038/ki.1978.23
  13. Choi Y, Kang HG, Park JM. Nephrotic syndrome in childhood. Korean J Nephrol 2002;21:356-61
  14. El-Husseini A, El-Basuonv F, Mahmoud I, Sheashaa H, Sabry A, Hassan R et al. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience. Nephrol Dial Transplant 2005;20:2433-8 https://doi.org/10.1093/ndt/gfi059
  15. The primary nephrotic syndrome in children. identification of patients with minimal change nephrotic syndrome frome initial response to prednisone. A report of the International Study of Kidney Disease in Children. J Pediatr 1981;98:561-4 https://doi.org/10.1016/S0022-3476(81)80760-3
  16. Cameron JS, Chantler C, Ogg CS, White RH. Long-term stability of remission in nephrotic syndrome after treatment with cyclophosphamide. Br Med J 1974;4:7-11 https://doi.org/10.1136/bmj.4.5935.7
  17. Chiu J, Drummond KN. Long-term follow-up of cyclophosphamide therapy in frequent relapsing minimal lesion nephrotic syndrome. J Pediatr 1974;84:825-30 https://doi.org/10.1016/S0022-3476(74)80757-2
  18. Schulman SL, Kaiser BA, Polinsky MS, Srinivasan R, Baluarte HJ. Predicting the response to cytotoxic therapy for childhood nephrotic syndrome: superiority of response to corticosteroid therapy over histopathologic patterns. J Pediatr 1988;113:996-1001 https://doi.org/10.1016/S0022-3476(88)80570-5
  19. Tarshish P, Tobin JN, Bernstein J, Edelmann CM Jr. Cyclophosphamide dose not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children. Pediatr Nephrol 1996;10:590-3 https://doi.org/10.1007/s004670050167
  20. Geary DF, Farine M, Thorner P, Baumal R. Response to cyclophosphamide in steroid-resistant focal segmental glomerulosclerosis: a reappraisal. Clin Nephrol 1984;22:109-13
  21. Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet 2003;362:629-39 https://doi.org/10.1016/S0140-6736(03)14184-0
  22. Niaudet P, Habib R. Cyclosporine in the treatment of idiopathic nephrosis. J Am Soc Nephrol 1994;5:1049-56
  23. Lieberman KV, Tejani A, A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children. J Am Soc Nephrol 1996;7:56-63
  24. Ponticelli C, Rizzoni G, Edefonti A, Altieri P, Rivolta E, Rinaldi S , et al. A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome. Kidney Int 1993;43:1377-84 https://doi.org/10.1038/ki.1993.194
  25. Niaudet P. Treatment of childhood steroid-resistant idiopathic nephrosis with a combination of cyclosporine and prednisone. French Society of Pediatric Nephrology. J Pediatr 1994;125:981-6 https://doi.org/10.1016/S0022-3476(05)82020-7
  26. Snyder SH, Sabatini DM, Lai MM, Steiner JP, Hamilton GS, Suzdak PD. Neural actions of immunophilin ligands. Trends Pharmacol Sci 1998;19:21-6 https://doi.org/10.1016/S0165-6147(97)01146-2
  27. Kahan BD. Cyclosporine. N Engl J Med 1989;321:1725-38 https://doi.org/10.1056/NEJM198912213212507
  28. Tejani A. Butt K, Trachtman H, Suthanthiran M, Rosen-thal CJ, Khawar MR. Cyclosporine induced remission of relapsing nephrotic syndrome in children. J Pediatr 1987;111:1056-62 https://doi.org/10.1016/S0022-3476(87)80056-2
  29. Kim PK, Kim JH, Chin HJ, Jeong HJ. Therapeutic effect of cyclosporine a on the severe Henoch-Scholein purpura nephritis. J Korean Soc Pediatr Nephrol 1998;2:110-7
  30. Niaudet P, Broyer M. Cyclosporine in the therapy of idiopathic nephrotic syndrome in children. International yearbook of nephrology. Kluwer Academic Publisher 1989:155-68
  31. Klintmalm G, Bohman SO, Sundelin B, Wilczek H. Interstitial fibrosis in renal allografts after 12 to 42 months of cyclosporine treatment: Beneficial effects of low dose in early post transplant period. Lancet 1984;2:950-4
  32. Neild GH, Reuben R, Hartley RB, Cameron JS. Glomerular thrombi in renal allografts associated with cyclosporine treatment. J Clin Pathol 1985;38:253-8 https://doi.org/10.1136/jcp.38.3.253